# Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

> **NCT02526368** · EARLY_PHASE1 · RECRUITING · sponsor: **Ivan de Kouchkovsky, MD** · enrollment: 80 (estimated)

## Conditions studied

- Prostate Cancer
- Localized Prostate Carcinoma

## Interventions

- **DRUG:** Hyperpolarized 13C-Pyruvate
- **DRUG:** Hyperpolarized 13C,15N2-urea
- **PROCEDURE:** Magnetic Resonance Spectroscopic Imaging

## Key facts

- **NCT ID:** NCT02526368
- **Lead sponsor:** Ivan de Kouchkovsky, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-03-22
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02526368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02526368, "Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02526368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*